explore -WSS

explore

author：fashion 2025-09-27 19:29:39 - browse：772

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

WSS

WHO may add ‘noma' to its list of neglected tropical diseases

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Cassava reveals details — and problems — with Alzheimer's study

A new deal aims to ramp up use of AI in rehab care decisions

Meta's Zuckerberg and Chan on track to put $50 billion into science

Hey, doctors: Don't be no

hotspot

explore

focus

Medicare details structure of new drug price negotiation program

Reframing the conversation around gain

What does generative AI mean for health care? We asked experts

How Brent Saunders' Allergan experiment failed

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Traditional Chinese medicine benefits explored in new JAMA study

Walensky prepares to leave CDC — and Congress — behind

What is the Turing Test that determines if computers can think?

Hepatitis C has a cure — but many Americans still lack access to it

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

hotspot

It's time to take a new tack for treating Alzheimer's

Why Sanofi got shellacked over its spinoff

Diversifying clinical trials isn't enough to close racial gaps: study

Testing for cancer recurrence creates a new limbo for patients

How Brent Saunders' Allergan experiment failed

The FDA weighs the risks of candy

focus

Wikipedia

focus

focus